Neurometabolic Testing in Developmental Delay

Abstract

The goal of this study was to examine the usefulness of neurometabolic testing in patients with unexplained developmental delay. We included 118 patients from ages 3 months to 13 years. The evaluation was conducted according to a protocol that called for stepwise investigations with the intention to minimize unnecessary tests. Clinical and neuroradiologic abnormalities were used as guidelines for the type and extent of the neurometabolic work-up. Based on our results, a diagnosis for a neurometabolic disorder was established in 16 patients (13.6%). Findings regarding abnormal metabolites (amino acids, ammonia, lactate, pyruvate, urine organic acids) did not lead to a diagnosis but to further investigations. Abnormalities in lysosomal enzymes, very-long-chain fatty acids, and urine mucopolysaccharides were definitive in establishing a diagnosis. In conclusion, in children with slowly progressing development with no apparent cause, there is a need for guidelines regarding the type of patients who need to be tested and the kind and extent of neurometabolic diagnostic work-up. (J Child Neurol 2000;15:620-622).

Get full access to this article

View all access options for this article.

References

Kristiansson B. , Andersson M. , Tonnby B. , Hagberg B. : Disialotransferrin developmental deficiency syndrome. Arch Dis Child 1989;64:71-76.

Blasco PA : Pitfalls in developmental diagnosis. Pediatr Clin North Am 1991;38:1425-1438.

Shonkoff JP , Hauser-Cram P: Early intervention for disabled infants and their families: A quantitative analysis. Pediatrics 1987;80:650-658.

Dunn D. , Epstein L. : Decision Making in Child Neurology. Hamilton, ON, BC Decker, 1987.

Jones KL : Smith's Recognizable Patterns of Human Malformation, 4th ed. Philadelphia, WB Saunders , 1988.

Shaw CM : Correlates of mental retardation and structural changes of the brain . Brain Dev 1987;9:1-8.

Applegarth DA , Dimmick JE , Toone SR : Laboratory detection of meta bolic disease . Pediatr Clin North Am 1989;36:49-64.

First LR , Palfrey YS : The infant or young child with developmental delay. N Engl J Med 1994;330:478-483.

Low JA , Galbraith RS , Muir DW , et al: The predictive significance of biologic risk factors for deficits in children of a high-risk population. Am J Obstet Gynecol 1983;145:1059-1068.

10.

Lyon G. , Adams R. , Kolodny E. : Neurology of Hereditary Metabolic Diseases of Children, 2nd ed. New York, McGraw-Hill , 1996.

11.

Aicardi J. : The etiology of developmental delay. Semin Pediatr Neurol 1998;5:15-20.

12.

Lamont MA , Dennis NR : Aetiology of mild mental retardation. Arch Dis Child 1988;63:1032-1038.

13.

Hagberg B. , Hagberg G. , Lewerth A. , Lindberg U. : Mild mental retardation in Swedish school children I. Acta Pediatr Scand 1981-170:441-444.

14.

Hagberg B. , Hagberg G. , Lewerth A. , Lindberg U. : Mild mental retardation in Swedish school children II. Acta Pediatr Scand 1981;70:445-452.

15.

Gerrits G. , Monnens L. , Gabreels F. , et al: Cerebrospinal fluid amino acids, purines and pyrimidines as a tool in the study of metabolic brain diseases. J Inherit Metab Dis 1993;16:670-675.

16.

Robertson P. , Buchanan D. , Muenzer J. : 5-Oxoprolinuria in an adolescent with chronic metabolic acidosis, mental retardation and psychosis . J Pediatr 1991;118:92-95.

17.

Einfeld SL Clinical assessment of 4500 developmentally delayed individuals. J Ment Defic Res 1984;28:129-142.

18.

Brusilow SW : Inborn errors of urea synthesis: Paradigm of hyperammonemic encephalopathy , in Berg B (ed): Principles of Child Neurology. New York, McGraw-Hill , 1996, pp 979—995.

19.

Nelson KB , Ellenberg JH : Antecedents of cerebral palsy, multivariate analysis of risk. N Engl J Med 1986;315:81-86.

20.

Bennet FC , Guralnick MJ : Effectiveness of developmental intervention in the first five years of life . Pediatr Clin North Am 1991;38: 1513-1528.

21.

Elpeleg O. , Amir N. , Christensen E. : Variability of clinical presentation in fumarate hydratase deficiency . J Pediatr 1992;121:752-754.